0.8399
price down icon2.55%   -0.022
after-market Handel nachbörslich: .82 -0.0199 -2.37%
loading
Schlusskurs vom Vortag:
$0.8619
Offen:
$0.86
24-Stunden-Volumen:
1.19M
Relative Volume:
1.26
Marktkapitalisierung:
$108.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.91M
KGV:
-3.8177
EPS:
-0.22
Netto-Cashflow:
$-19.57M
1W Leistung:
-0.24%
1M Leistung:
-2.54%
6M Leistung:
-9.81%
1J Leistung:
-40.43%
1-Tages-Spanne:
Value
$0.8068
$0.8629
1-Wochen-Bereich:
Value
$0.8068
$0.8909
52-Wochen-Spanne:
Value
$0.5526
$1.66

Atossa Therapeutics Inc Stock (ATOS) Company Profile

Name
Firmenname
Atossa Therapeutics Inc
Name
Telefon
206.588.0256
Name
Adresse
10202 5TH AVENUE NE, SEATTLE, WA
Name
Mitarbeiter
13
Name
Twitter
@atossainc
Name
Nächster Verdiensttermin
2025-03-25
Name
Neueste SEC-Einreichungen
Name
ATOS's Discussions on Twitter

Vergleichen Sie ATOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATOS
Atossa Therapeutics Inc
0.8399 111.33M 0 -26.91M -19.57M -0.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2018-01-26 Eingeleitet Maxim Group Buy

Atossa Therapeutics Inc Aktie (ATOS) Neueste Nachrichten

pulisher
Jul 25, 2025

Is Atossa Therapeutics Inc. a good long term investmentHigh-impact investment strategies - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Atossa Therapeutics Inc. Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Atossa Therapeutics Inc. stockFree Market Volatility Navigation Tips - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Does Atossa Therapeutics Inc. stock pay reliable dividendsFree Consultation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Why Atossa Therapeutics Inc. stock attracts strong analyst attentionMarket Beating Strategy - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Will Atossa Therapeutics Inc. stock split in the near futureDynamic investment growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

How Atossa Therapeutics Inc. stock reacts to Fed policy changesStrongest growth potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Atossa Therapeutics Inc. stock priceExceptional profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 18, 2025

Should I buy Atossa Therapeutics Inc. stock before earningsHigh Win Rate Stock Ideas - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Atossa Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atossa Therapeutics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser

Jul 15, 2025
pulisher
Jul 07, 2025

Ascendiant Lifts Atossa Therapeutics, Inc. (ATOS) Target Citing Strong Liquidity - MSN

Jul 07, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Purchases Shares of 29,149 Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Jun 15, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Craig Hallum Upgrades Atossa Therapeutics (NASDAQ:ATOS) to “Strong-Buy” - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Targ - GuruFocus

Jun 06, 2025

Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):